ENTITY
Innocare Pharma
Innocare Pharma
PulseAugur coverage of Innocare Pharma — every cluster mentioning Innocare Pharma across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Innocare Pharma's ITP drug application accepted by China regulators
A new drug, 奥布替尼 (Obutini), developed by Innocare Pharma, has had its new drug application accepted by China's National Medical Products Administration for treating primary immune thrombocytopenia (ITP). This marks the …
-
Li Auto delivers 95K vehicles in Q1, Innocare's ITP drug accepted
Li Auto reported first-quarter deliveries of 95,142 vehicles, a 2.5% increase year-over-year, reclaiming the top sales spot among Chinese brands in the new energy vehicle market above 200,000 yuan. The company's first-q…